21 Rue de la Noue Bras De Fer
44 200 NANTES
FRANCE

+33 2 28 29 02 62

+33 2 44 84 78 05

contact@i-sep.com

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
News
05 . 09 . 22

Same™ by I-SEP medical device has obtained the CE mark and started marketing

i-SEP announces the CE marking and marketing of its autotransfusion medical device: same™ by i-SEP. For the past several months I-SEP…

Read
Chronicle
11 . 02 . 22

🚨🩸“Every donation is critical and you can make a lifesaving difference.”…

🚨🩸“Every donation is critical and you can make a lifesaving difference.”… This is what appears first on the American Red…

Read
News
17 . 12 . 21

same™ by i-SEP: the first intraoperative autotransfusion technology able to recover platelets as well as red blood cells

Thank you to Business France North America and French Healthcare for highlighting our innovative Intraoperative Cell Recovery technology and its…

Read
Event
29 . 10 . 21

EACTAIC/ICCVA congress 2021

🌍🩸A world premiere: This morning the first communication of our clinical results have been presenting by Doctor Alexandre Mansour in…

Read
News
15 . 10 . 21

⭐️A major milestones for i-SEP and improvement of Patient Blood Management

🌟A major milestones for i-SEP and for improvement of Patient Blood Management program thanks to our innovative IntraOperative Cell Recovery…

Read
Event
28 . 07 . 21

SFAR 2021 Congress september 23rd-25th, Paris Palais des Congrès Paris, Porte Maillot

[EVENT] Meet us and discover our unique autotransfusion technology in the exhibition area of the #SFAR2021 booth F3, from September 23…

Read
News
28 . 05 . 21

Promising preclinical results for patients and physicians published in the prestigious journal Anesthesiology

Innovative medical device same™ by i-SEP: The publication of the preclinical results obtained in recent months in collaboration with academic and…

Read
News
02 . 06 . 20

i-SEP authorized by ANSM and AFMPS to launch its clinical trial in France and Belgium

I-SEP, a French Medtech company based in Nantes, specialized in blood treatment and Patient Blood Management3, has developed and patented…

Read
News
24 . 10 . 19

i-SEP raises €2.5 million for its innovative autotransfusion technology

i-SEP has raised a third round of funds of €2.5 million from its initial shareholders, including the venture capital fund…

Read
News
14 . 10 . 19

i-SEP: A boss with innovation in the blood…

One year after having received €3 million in aid under the PIA Investing-for-the-Future Program, i-SEP is continuing its momentum and…

Read
News
14 . 10 . 19

i-SEP simplifies autotransfusion

The Nantes-based start-up i-SEP is preparing to raise €2 million before summer. Bolstered by its resources, this Medtech company, founded…

Read
Chronicle
08 . 10 . 19

Radio: i-SEP interview by Europe 1 radio show (“innovation of the day”)

Surgery: the auto-transfusion of patients will soon be possible during operations. A French innovation to overcome platelet shortages and minimize…

Read